Neurelis' Debt - II Round

Neurelis raised a round of funding on August 24, 2018.

Neurelis is a privately-held San Diego-based specialty pharmaceutical company organized to license, develop, and commercialize product candidates for epilepsy and the broader central nervous system (C…

Articles about Neurelis' Debt - II Round: